Nephrol Dial Transplant (1999) 14: 2427-2432
© 1999 European Renal Association-European Dialysis and Transplant Association
Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients
1 Department of Clinical Nutrition, School of Food and Nutritional Sciences, University of Shizuoka, Shizuoka, 2 Kidney Center, Iwata City Hospital, Iwata, 3 Nishikino Hospital, Fujieda, and 4 First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
Correspondence and offprint requests to: Hiromichi Kumagai MD, Associate Professor, Department of Clinical Nutrition, School of Food and Nutritional Sciences, University of Shizuoka, 52–1 Yada, Shizuoka 422, Japan.
Background. Disturbances of lipid and carbohydrate metabolism may be associated with the distribution of abdominal adiposity. However, little is known about the alteration of abdominal adiposity and its association with the serum lipid profile in haemodialysis patients.
Methods. We evaluated the distribution of abdominal adiposity by using computed tomography and examined its relationship with the serum lipid profile in 92 non-diabetic haemodialysis patients and 80 control subjects with normal renal function. Since the mean body mass index (BMI) and total body fat mass were significantly lower in the haemodialysis patients than in the control subjects, the subcutaneous abdominal fat area and the visceral fat area were standardized by body mass index and compared between the haemodialysis patients and the control subjects.
Results. Mean subcutaneous fat area/body mass index (SFA/BMI) was significantly lower, and mean visceral fat area/body mass index (VFA/BMI) was significantly higher in the haemodialysis patients (SFA/BMI, 2.40±0.12; VFA/BMI, 2.28±0.15) than in the control subjects (SFA/BMI, 3.75±0.21, P<0.01; VFA/BMI, 1.65±0.15, P<0.01). Consequently, visceral fat area/subcutaneous fat area ratio was significantly higher in the haemodialysis patients (1.05±0.07) than in the control subjects (0.46±0.04, P<0.01). A scattered plot of visceral fat area relative to BMI revealed that visceral fat area was higher in the haemodialysis patients than in the control subjects at any BMI level. A simple regression analysis showed that BMI, total body fat mass, subcutaneous fat area and visceral fat area were all associated with serum triglycerides and the atherogenic index, (total cholesterol–HDL cholesterol)/HDL cholesterol. Furthermore, a multiple regression analysis indicated that the visceral fat area was the best predictor for either the atherogenic index or triglycerides among these fat components.
Conclusions. These data indicate that haemodialysis patients exhibited a visceral fat accumulation irrespective of BMI, and this shift of abdominal adiposity might be associated with disturbance of the serum lipid profile in non-diabetic haemodialysis patients.
Keywords: abdominal fat distribution; atherosclerosis; haemodialysis; lipid metabolism; visceral fat
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Gotoh, T. Gohda, M. Tanimoto, Y. Gotoh, S. Horikoshi, and Y. Tomino Contribution of subcutaneous fat accumulation to insulin resistance and atherosclerosis in haemodialysis patients Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3474 - 3480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Cordeiro, A. R. Qureshi, P. Stenvinkel, O. Heimburger, J. Axelsson, P. Barany, B. Lindholm, and J. J. Carrero Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis Nephrol. Dial. Transplant., September 17, 2009; (2009) gfp492v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Sakkas, C. Karatzaferi, E. Zintzaras, C. D. Giannaki, V. Liakopoulos, E. Lavdas, E. Damani, N. Liakos, I. Fezoulidis, Y. Koutedakis, et al. Liver fat, visceral adiposity, and sleep disturbances contribute to the development of insulin resistance and glucose intolerance in nondiabetic dialysis patients Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1721 - R1729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Sakkas, K. I. Gourgoulianis, C. Karatzaferi, V. Liakopoulos, M. D. Maridaki, C. Pastaka, E. Lavdas, B. J. Soher, S. Dovas, I. Fezoulidis, et al. Haemodialysis patients with sleep apnoea syndrome experience increased central adiposity and altered muscular composition and functionality Nephrol. Dial. Transplant., January 1, 2008; 23(1): 336 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ohkawa, M. Odamaki, N. Ikegaya, I. Hibi, K. Miyaji, and H. Kumagai Association of age with muscle mass, fat mass and fat distribution in non-diabetic haemodialysis patients Nephrol. Dial. Transplant., May 1, 2005; 20(5): 945 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J Foster and M. B Leonard Measuring nutritional status in children with chronic kidney disease Am. J. Clinical Nutrition, October 1, 2004; 80(4): 801 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yamauchi, T. Kuno, H. Takada, Y. Nagura, K. Kanmatsuse, and S. Takahashi The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients Nephrol. Dial. Transplant., September 1, 2003; 18(9): 1842 - 1847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. ISHIMURA, S. OKUNO, M. KIM, T. YAMAMOTO, T. IZUMOTANI, T. OTOSHI, T. SHOJI, M. INABA, and Y. NISHIZAWA Increasing Body Fat Mass in the First Year of Hemodialysis J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1921 - 1926. [Abstract] [Full Text] [PDF]
|
|